Stent Thrombogenicity Early in High Risk Interventional Settings is Driven by Stent Design and Deployment, and Protected by Polymer-Drug Coatings
Author Manuscript: 2012 April 5
Main Authors: | , , , , , , , , |
---|---|
Other Authors: | |
Format: | Article |
Language: | en_US |
Published: |
American Heart Association
2012
|
Online Access: | http://hdl.handle.net/1721.1/75397 https://orcid.org/0000-0003-3159-8175 https://orcid.org/0000-0002-7832-7156 |